114 related articles for article (PubMed ID: 6821814)
1. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
Neuwelt EA; Kikuchi K; Hill S; Lipsky P; Frenkel EP
Cancer; 1983 Jan; 51(2):248-55. PubMed ID: 6821814
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
McVicar DW; Davis DF; Merchant RE
J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
[TBL] [Abstract][Full Text] [Related]
3. Impaired thymus-derived lymphocyte function in patients with malignant brain tumour.
Menzies CB; Gunar M; Thomas DG; Behan PO
Clin Neurol Neurosurg; 1980; 82(3):157-68. PubMed ID: 6260411
[TBL] [Abstract][Full Text] [Related]
4. Presence of immunosuppressive factors in brain-tumor cyst fluid.
Kikuchi K; Neuwelt EA
J Neurosurg; 1983 Nov; 59(5):790-9. PubMed ID: 6619930
[TBL] [Abstract][Full Text] [Related]
5. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
6. In vitro demonstration of cell-mediated immunity to human brain tumors.
Levy NL; Mahaley MS; Day ED
Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
[No Abstract] [Full Text] [Related]
7. Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.
Elliott LH; Brooks WH; Roszman TL
J Neurosurg; 1987 Aug; 67(2):231-6. PubMed ID: 2885402
[TBL] [Abstract][Full Text] [Related]
8. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
Levy NL
J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
[No Abstract] [Full Text] [Related]
9. General immunocompetence of rats bearing avian sarcoma virus-induced intracranial tumors.
Roszman TL; Brooks WH; Markesbery WR; Bigner DD
Cancer Res; 1978 Jan; 38(1):74-7. PubMed ID: 201377
[TBL] [Abstract][Full Text] [Related]
10. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
Blomgren H; Blom U; Ullén H
Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
[TBL] [Abstract][Full Text] [Related]
11. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
[TBL] [Abstract][Full Text] [Related]
12. Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.
Wood GW; Morantz RA
J Neurooncol; 1983; 1(2):87-94. PubMed ID: 6236289
[TBL] [Abstract][Full Text] [Related]
13. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
14. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
Böker DK
Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
[TBL] [Abstract][Full Text] [Related]
15. A correlation between serum immunosuppressive acidic protein and altered immunocompetence in patients with brain tumours.
Kikuchi K; Gotoh H; Kowada M
Acta Neurochir (Wien); 1990; 103(1-2):52-61. PubMed ID: 2360468
[TBL] [Abstract][Full Text] [Related]
16. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.
Gately MK; Glaser M; Dick SJ; Mettetal RW; Kornblith PL
J Natl Cancer Inst; 1982 Dec; 69(6):1245-54. PubMed ID: 6183477
[TBL] [Abstract][Full Text] [Related]
18. [Lymphocyte subpopulations and their functional activity in patients with brain tumors].
Rudenko VA; Lisianyĭ NI; Radzievskiĭ AA
Vrach Delo; 1990 Sep; (9):91-4. PubMed ID: 2284786
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell-mediated immunity in patients with brain tumors.
Young HF; Sakalas R; Kaplan AM
Surg Neurol; 1976 Jan; 5(1):19-23. PubMed ID: 1265620
[TBL] [Abstract][Full Text] [Related]
20. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.
Brooks WH; Roszman TL; Rogers AS
Cancer; 1976 Apr; 37(4):1869-73. PubMed ID: 769940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
